[The effect of essential phospholipids following acute experimental CCl4 liver injury].
D000284:Administration, Oral; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001463:Barbiturates / Q000494:pharmacology; D002252:Carbon Tetrachloride Poisoning / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D007275:Injections, Intravenous; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008055:Lipids / Q000097:blood; D008297:Male; D010743:Phospholipids / Q000097:blood / Q000627:therapeutic use*; D051381:Rats; D012709:Serum Albumin / Q000378:metabolism; D012712:Serum Globulins / Q000378:metabolism; D014280:Triglycerides / Q000097:blood
D001463:Barbiturates; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D010743:Phospholipids; D012709:Serum Albumin; D012712:Serum Globulins; D014280:Triglycerides; D002784:Cholesterol; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Die Wirkung essentieller Phospholipide bei der akuten experimentellen leberschädigung durch CCl4.